|
|
Indian company gets Britain's approval for bulk tablets
Mar 8, 2006, 21:45, Reviewed by: Dr. Priya Saxena
|
|
"With this first approval for the formulation plant having been received in record time, the company is closer to commercialising its plan in integrating its support operations in the complete value chain of pharma business,"
|
By IANS,
Chennai-based Shasun Chemicals and Drugs Ltd Wednesday said it received approval from Britain for its oral solid dosage forms for the bulk tablets market.
With the approval from the British Medicines and Healthcare products Regulatory Agency (MHRA), Shasun's products from its formulation facility in Pondicherry can now be sold in Britain and other European countries.
Shasun's plant at Pondicherry, set up in 2005, has a capacity to produce 3.6 billion tablets per year.
"With this first approval for the formulation plant having been received in record time, the company is closer to commercialising its plan in integrating its support operations in the complete value chain of pharma business," Vimal Kumar, Shasun's joint managing director told reporters Wednesday.
"Going forward, we expects this approval to enhance our capabilities to support the requirements of companies worldwide, providing back end manufacturing support across the complete pharmaceutical value chain," he said.
- Indo-Asian News Service
For any corrections of factual information, to contact the editors or to send
any medical news or health news press releases, use
feedback form
Top of Page
|
|
|
|